These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

47 related articles for article (PubMed ID: 7712623)

  • 1. Plasma vigabatrin enantiomer ratios in adults and children.
    Nagarajan L; Schramm T; Appleton DB; Burke CJ; Eadie MJ
    Clin Exp Neurol; 1993; 30():127-36. PubMed ID: 7712623
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Vigabatrin--plasma enantiomer concentrations and clinical effects.
    Sheean G; Schramm T; Anderson DS; Eadie MJ
    Clin Exp Neurol; 1992; 29():107-16. PubMed ID: 1343855
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Vigabatrin. Clinical pharmacokinetics.
    Rey E; Pons G; Olive G
    Clin Pharmacokinet; 1992 Oct; 23(4):267-78. PubMed ID: 1395360
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Fluorescent high-performance liquid chromatographic analysis of vigabatrin enantiomers after derivatizing with naproxen acyl chloride.
    Hsieh CY; Wang SY; Kwan AL; Wu HL
    J Chromatogr A; 2008 Jan; 1178(1-2):166-70. PubMed ID: 18082755
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Pharmacokinetics of the individual enantiomers of vigabatrin in neonates with uncontrolled seizures.
    Vauzelle-Kervroëdan F; Rey E; Pons G; d'Athis P; Chiron C; Dulac O; Dumas C; Olive G
    Br J Clin Pharmacol; 1996 Dec; 42(6):779-81. PubMed ID: 8971436
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Pharmacokinetics of the individual enantiomers of vigabatrin (gamma-vinyl GABA) in epileptic children.
    Rey E; Pons G; Richard MO; Vauzelle F; D'Athis P; Chiron C; Dulac O; Beaumont D; Olive G
    Br J Clin Pharmacol; 1990 Aug; 30(2):253-7. PubMed ID: 2206786
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Vigabatrin increases human brain homocarnosine and improves seizure control.
    Petroff OA; Mattson RH; Behar KL; Hyder F; Rothman DL
    Ann Neurol; 1998 Dec; 44(6):948-52. PubMed ID: 9851440
    [TBL] [Abstract][Full Text] [Related]  

  • 8. [Vigabatrin--a new antiepileptic agent].
    Nakken KO; Henriksen O; Johannessen SI
    Tidsskr Nor Laegeforen; 1994 Oct; 114(24):2843-4. PubMed ID: 7998031
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Enantiomer-selective pharmacokinetics and metabolism of ketorolac in children.
    Kauffman RE; Lieh-Lai MW; Uy HG; Aravind MK
    Clin Pharmacol Ther; 1999 Apr; 65(4):382-8. PubMed ID: 10223774
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Vigabatrin serum concentration to dosage ratio: influence of age and associated antiepileptic drugs.
    Armijo JA; Cuadrado A; Bravo J; Arteaga R
    Ther Drug Monit; 1997 Oct; 19(5):491-8. PubMed ID: 9357089
    [TBL] [Abstract][Full Text] [Related]  

  • 11. A direct HPLC method for the resolution and quantitation of the R-(-)- and S-(+)-enantiomers of vigabatrin (gamma-vinyl-GABA) in pharmaceutical dosage forms using teicoplanin aglycone chiral stationary phase.
    Al-Majed AA
    J Pharm Biomed Anal; 2009 Aug; 50(1):96-9. PubMed ID: 19446423
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Vigabatrin: new indication. An advance in infantile spasms.
    Prescrire Int; 1998 Apr; 7(34):43-4. PubMed ID: 10183381
    [TBL] [Abstract][Full Text] [Related]  

  • 13. [Treatment of refractory infantile epilepsy with vigabatrin in a series of 55 patients].
    López-Valdés E; Hernández-Laín A; Simón R; Porta J; Mateos F
    Rev Neurol; 1996 Oct; 24(134):1255-7. PubMed ID: 8983724
    [TBL] [Abstract][Full Text] [Related]  

  • 14. [Efficacy of vigabatrin associated with carbamazepine in the treatment of epilepsy. Follow up 1993-1996].
    De Romanis F; Sopranzi N
    Clin Ter; 1998; 149(2):131-4. PubMed ID: 9780478
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Pharmacokinetics of the S(+) and R(-) enantiomers of vigabatrin during chronic dosing in a patient with renal failure.
    Jacqz-Aigrain E; Guillonneau M; Rey E; Macher MA; Montes C; Chiron C; Loirat C
    Br J Clin Pharmacol; 1997 Aug; 44(2):183-5. PubMed ID: 9278207
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Rufinamide: clinical pharmacokinetics and concentration-response relationships in patients with epilepsy.
    Perucca E; Cloyd J; Critchley D; Fuseau E
    Epilepsia; 2008 Jul; 49(7):1123-41. PubMed ID: 18503564
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Drug dependence study on vigabatrin in rhesus monkeys and rats.
    Takada K; Yanagita T
    Arzneimittelforschung; 1997 Oct; 47(10):1087-92. PubMed ID: 9368699
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Behavioral effects of vigabatrin correlated with whole brain gamma-aminobutyric acid metabolism in audiogenic sensitive rats.
    Engelborghs S; Pickut BA; D'Hooge R; Wiechert P; Haegele K; De Deyn PP
    Arzneimittelforschung; 1998 Jul; 48(7):713-6. PubMed ID: 9706369
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Vigabatrin: placental transfer in vivo and excretion into breast milk of the enantiomers.
    Tran A; O'Mahoney T; Rey E; Mai J; Mumford JP; Olive G
    Br J Clin Pharmacol; 1998 Apr; 45(4):409-11. PubMed ID: 9578192
    [TBL] [Abstract][Full Text] [Related]  

  • 20. High-performance liquid chromatographic analysis of vigabatrin enantiomers in human serum by precolumn derivatization with o-phthaldialdehyde-N-acetyl-L-cysteine and fluorescence detection.
    Vermeij TA; Edelbroek PM
    J Chromatogr B Biomed Sci Appl; 1998 Sep; 716(1-2):233-8. PubMed ID: 9824236
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 3.